Ocular toxoplasmosis in pregnancy

Clinical and Experimental Ophthalmology

Volumn 33, Issue 5, 2005, Pages 455-460

  Kump, Leila I ^a,b   Androudi, Sofia N ^a   Foster, C S ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

Author keywords

Ocular inflammation; Pregnancy; Toxoplasmosis

Indexed keywords

ATOVAQUONE; BRIMONIDINE; CLINDAMYCIN; FOLINIC ACID; PREDNISOLONE ACETATE; PREDNISONE; PYRIMETHAMINE; SCOPOLAMINE; SULFADIAZINE; TIMOLOL MALEATE; ANTIPROTOZOAL AGENT; GLUCOCORTICOID;

ADULT; ARTICLE; CASE REPORT; CASE STUDY; CHORIORETINITIS; DELIVERY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; PREGNANCY; PREGNANT WOMAN; RECURRENT INFECTION; RETROSPECTIVE STUDY; TOXOPLASMOSIS; VISUAL ACUITY; DRUG COMBINATION; DRUG RESISTANCE; GESTATIONAL AGE; PARASITOLOGY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; RECURRENT DISEASE; VISUAL DISORDER;

ADULT; ANTIPROTOZOAL AGENTS; CHORIORETINITIS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; GESTATIONAL AGE; GLUCOCORTICOIDS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PREGNANCY OUTCOME; RECURRENCE; RETROSPECTIVE STUDIES; TOXOPLASMOSIS, OCULAR; VISION DISORDERS; VISUAL ACUITY;

EID: 33644792022     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2005.01061.x     Document Type: Article

References (40)

1. Fernandes LC, Oréfice F. Aspectos clinicos e epidemiologicos das uveitis em service de referencia em Belo Horizonte 1970-1993. Rev Bras Oftal 1996;55:569-92.
2. Da Mata AP, Oréfice F. Toxoplasmosis. In: Foster CS, Vitale AT, eds. Diagnosis and Treatment of Uveitis. Philadelphia: WB Saunders Company, 2002;385-410.
3. Holland GN. LX Edward Jackson Memorial lecture. Ocular toxoplasmosis: A global reassessment. Part I: Epidemiology and course of disease. Am J Ophthalmol 2003;136:973-88.
4. Silveira CM, Belfort R Jr, Burnier M, Nussenblatt RB. Acquired toxoplasmosis infection as the cause of toxoplasmic retinochoroiditis in families. Am J Ophthalmol 1988;106:362-4.
5. Glasner PD, Silveira C, Kruszon Moran D et al. An unusually high prevalence of ocular toxoplasmosis in Southern Brazil. Am J Ophthalmol 1992;114:136-44.
6. Burnett AJ, Shortt SG, Isaac-Renton J et al. Multiple cases of acquired toxoplasmosis retinitis presenting in an outbreak. Ophthalmology 1998;105:1032-7.
7. Melamed JC. Acquired ocular toxoplasmosis - late onset. In: Nussenblatt RB, ed. Advances in Ocular Immunology: Proceedings of the 6th International Symposium on the Immunology and Immunopathology of the Eye. New York: Elsevier, 1994;449-52.
8. Mets MB, Holfels E, Boyer KM et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 1996;122:309-24.
9. Kump LI, Cervantes Castañeda RA, Androudi SN, Christen WG, Foster CS. Patterns of exacerbations of chronic non-infectious uveitis in pregnancy and puerperium. Ocul Immunol Inflamm 2005; (in press).
10. Holland GN, O'Connor GR, Belfort R, Remington JS. Toxoplasmosis. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection and Immunity. St. Louis, MO: Mosby-Year Book, 1996;1183-223.
11. Friedman CT, Knox DL. Variations in recurrent active retinochoroiditis. Arch Ophthalmol 1969;81:481-93.
12. Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, Rothova A. Ocular toxoplasmosis: Clinical features and prognosis of 154 patients. Ophthalmology 2002;109:869-78.
13. Poser S, Poser W. Multiple sclerosis and gestation. Neurology 1983;33:1422-7.
14. Frith JA, Mcleod JG. Pregnancy and multiple sclerosis. J Neurol Neurosurg Psychiatry 1988;51:495-8.
15. Birk K, Ford C, Smeltzer S et al. The clinical course of multiple sclerosis during pregnancy and the puerperium. Arch Neurol 1990;47:738-42.
16. Confavreux C, Hutchinson M, Hours M et al. Rate of pregnancy related relapses in multiple sclerosis. N Eng J Med 1998;339:285-91.
17. Da Silva JA, Spector TD. The role of pregnancy in the course and aetiology of rheumatoid arthritis. Clin Rheumatol 1992;11:189-94.
18. Ostensen M, Hugsby G. A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum 1996;26:1155-9.
19. Ostensen M. Pregnancy in patients with a history of juvenile rheumatoid arthritis. Arthritis Rheum 1991;34:981-7.
20. Mayock RL, Sullivan RD, Greening RR, Jones R Jr. Sarcoidosis and pregnancy. JAMA 1957;164:158-63.
21. Holland GN. Ocular toxoplasmosis in the immunocompromised host. Int Ophthalmol 1989;13:399-402.
22. Holland GN, Engstrom RE, Glasgow BJ et al. Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 1988;106:653-67.
23. Moorthy RS, Smith RE, Rao NA. Progressive ocular toxoplasmosis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 1993;115:742-7.
24. Johnson MW, Greven GM, Jaffe GJ et al. Atypical, severe toxoplasmic retinochoroiditis in elderly patients. Ophthalmology 1997;104:48-57.
25. Labalette P, Delhaes F, Margaron F et al. Ocular toxoplasmosis after the fifth decade. Am J Ophthalmol 2002;133:506-15.
26. Holland GN, Lewis KG. An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 2002;134:102-14.
27. Donders GG. Treatment of sexually transmitted bacterial diseases in pregnant women. Drugs 2000;59:477-85.
28. Ramsey PS, Vaules MB, Vasdev GM et al. Maternal and transplacental pharmacokinetics of azithromycin. Am J Obstet Gynecol 2003;188:714-18.
29. Apgar BS, Greenberg G, Yen LI. Prevention of group B streptococcal disease in the newborn. Am Fam Physician 2005;71:903-10.
30. Ugwumadu A, Reid F, Hay P et al. Natural history of bacterial vaginosis and intermediate flora in pregnancy and effect of oral clindamycin. Obstet Gynecol 2004;104:114-19.
31. Taylor WR, White NJ. Antimalarial drug toxicity: A review. Drug Saf 2004;27:25-61.
32. McGready R, Stepniwska K, Edstein MD et al. The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria. Eur J Clin Pharmacol 2003;59:545-52.
33. Stanford MR, See SE, Jones LV, Gilbert RE. Antibiotics for toxoplasmic retinochoroiditis: An evidence-based systematic review. Ophthalmology 2003;110:926-32.
34. Mets MB, Holfels E, Boyer KM et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 1996;122:309-24.
35. Couvrier J, Desmonts G, Thulliez P. Prophylaxis of congenital toxoplasmosis: Effects of spiramycin on placental infection. J Antimicrob Chemother 1998;22(Suppl.B):193-200.
36. Hohlfels P, Daffos F, Thulliez P et al. Fetal toxoplasmosis: Outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr 1989;115:765-9.
37. Daffos F, Forestier F, Capella-Pavlovsky M. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Eng J Med 1988;318:271-5.
38. Silveira C, Belfort R Jr, Muccioli C et al. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol 2002;134:41-6.
39. Martinez CE, Zhang D, Conway MD, Peyman GA. Successful management of ocular toxoplasmosis during pregnancy using combined intraocular clindamycin and dexamethasone with systemic sulfadiazine. Int Ophthalmol 1998-99;22:85-8.
40. Kump LI, Foster CS. Intraocular drug delivery in patients with uveitis under special circumstances. Br J Ophthalmol (in press).